Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03849651 · FLOW

Participant flow

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · Source last updated 2026-07-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^5 cells/kg
    id
    FG000
    title
    Dose Level 1 Transplant Participants
  2. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^6 cells/kg
    id
    FG001
    title
    Dose Level 2 Transplant Participants
  3. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^7 cells/kg
    id
    FG002
    title
    Dose Level 3 Transplant Participants
  4. description
    Patients who met eligibility criteria, received transplant, and received the MED dose of 1x10\^7 cells/kg
    id
    FG003
    title
    Phase 2 Transplant Participants
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        10
      3. group Id
        FG002
        num Subjects
        10
      4. group Id
        FG003
        num Subjects
        40
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        10
      3. group Id
        FG002
        num Subjects
        10
      4. group Id
        FG003
        num Subjects
        38
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^5 cells/kg
    id
    FG000
    title
    Dose Level 1 Transplant Participants
  2. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^6 cells/kg
    id
    FG001
    title
    Dose Level 2 Transplant Participants
  3. description
    Patients who met eligibility criteria, received transplant, and received 1x10\^7 cells/kg
    id
    FG002
    title
    Dose Level 3 Transplant Participants
  4. description
    Patients who met eligibility criteria, received transplant, and received the MED dose of 1x10\^7 cells/kg
    id
    FG003
    title
    Phase 2 Transplant Participants
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        10
      3. group Id
        FG002
        num Subjects
        10
      4. group Id
        FG003
        num Subjects
        40
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        10
      3. group Id
        FG002
        num Subjects
        10
      4. group Id
        FG003
        num Subjects
        38
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice